flaxanger0

About

Long-term benefits in patients together with superior and/or metastatic non-small cellular united states which concluded Two years involving immune checkpoint inhibitors or attained a resilient result following discontinuation without disease further advancement: Multicenter, real-world files (KCSG LU20-11).